C3i Center Contract Manufacturing & Development (CDMO) Profile
C3i is a fully integrated CDMO in CGT manufacturing. Offer flexible model to accomodate needs of early cell and gene therapy companies with phase appropriate Qc testing. We manufacture from process development to commercial. C3i is the 1st and only CDMO in Canada with a license to manufacture commercial cell therapies. C3i expects to obtain commercial authorization for the EU and FDA market in 2025.
CDMO Services:
Cell & Gene Therapy Drug Substance Manufacturing (API); Drug Product Formulation (FDF); Research & Development; Clinical Trials materials and logistics; Regulatory Services; Analytical Development Cartridges; Liquids Analytical Development; Cell Line Development; Formulation Development; ICH Stability Testing; Process Development Live Biotherapeutic Products
Year Founded: 1992
Head Office: Montréal, Canada
Number of Facilities: 1
Facility locations: North America
Website: Visit the C3i Center website
Linkedin: Connect on Linkedin
Current Capacity: C3i can onboard additional clients that are looking for process development to manufacturing of marketed cell therapies.